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Evidence shows altered somatosensory temporal discrimination threshold (STDT) in 
Parkinson’s disease in comparison to normal subjects. In healthy subjects, movement 
execution modulates STDT values through mechanisms of sensory gating. We investi-
gated whether STDT modulation during movement execution in patients with Parkinson’s 
disease differs from that in healthy subjects. In 24 patients with Parkinson’s disease and 
20 healthy subjects, we tested STDT at baseline and during index finger abductions (at 
movement onset “0”, 100, and 200 ms thereafter). We also recorded kinematic features 
of index finger abductions. Fifteen out of the 24 patients were also tested ON medication. 
In healthy subjects, STDT increased significantly at 0, 100, and 200 ms after movement 
onset, whereas in patients with Parkinson’s disease in OFF therapy, it increased signifi-
cantly at 0 and 100 ms but returned to baseline values at 200 ms. When patients were 
tested ON therapy, STDT during index finger abductions increased significantly, with a time 
course similar to that of healthy subjects. Differently from healthy subjects, in patients with 
Parkinson’s disease, the mean velocity of the finger abductions decreased according to 
the time lapse between movement onset and the delivery of the paired electrical stimuli for 
testing somatosensory temporal discrimination. In conclusion, patients with Parkinson’s 
disease show abnormalities in the temporal coupling between tactile information and motor 
outflow. Our study provides first evidence that altered temporal processing of sensory 
information play a role in the pathophysiology of motor symptoms in Parkinson’s disease.
Keywords: Parkinson’s disease, temporal processing, somatosensory temporal discrimination threshold, 
movement, sensorimotor integration, basal ganglia
inTrODUcTiOn
Sensorimotor integration is the process whereby incoming sensory information is continuously 
monitored so as to allow the current motor plan to be adjusted and voluntary movements to be 
executed accurately (1–5). Sensorimotor integration depends also on the temporal processing of 
sensory information. In humans, one way to assess temporal processing of sensory information is 
to calculate the somatosensory temporal discrimination threshold (STDT)—the shortest interval at 
which an individual recognizes paired stimuli as separate in time (6–9). In a recent study on healthy 
subjects, we used the STDT to provide new evidence showing that movement execution brings about 
changes in the temporal processing of tactile information through the interplay between the basal 
ganglia and thalamus (10).


















1 5 3 12 20 16 27
2 9 1.5 11 18 17 27
3 4 2 8 14 17 25
4 6 2 15 23 16 27
5 2 2 13 20 17 27
6 3 2 12 20 15 26
7 6 2 10 15 16 25
8 1 1.5 14 20 17 28
9 4 1 8 12 16 28
10 3 2 14 22 16 28
11 5 3 16 26 16 28
12 4 3 14 19 17 29
13 3 2.5 7 12 17 28
14 1 3 22 30 15 25
15 7 2 14 23 17 29
16 1 1.5 − 10 16 28
17 4 1 − 16 15 27
18 9 2 − 21 16 28
19 2 2 − 22 18 27
20 4 2.5 – 43 15 26
21 4 2 – 19 16 28
22 3 2 – 21 16 26
23 3 2 – 19 17 27
24 1 1.5 – 12 18 29
Mean 3.9 2.1 12.6 19.8 16.3 27.2
SD 2.2 0.5 3.7 6.9 0.8 1.4
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Several studies have consistently reported abnormally high 
STDT values in patients with Parkinson’s disease (6, 11–15). 
STDT abnormalities in PD patients parallel disease severity and 
duration and are partially improved by dopaminergic medication 
(6, 11–16). Whether STDT modulation during movement execu-
tion in PD is abnormal and whether any abnormalities in STDT 
modulation contribute to motor symptoms in PD is unclear. 
Knowing more about tactile information during movement 
execution would increase our understanding of the pathophysiol-
ogy of motor symptoms in PD.
The aim of this study was to investigate whether STDT modu-
lation during movement execution in PD patients differs from 
that in healthy subjects and to evaluate changes in the kinematic 
properties of movements during the sensorimotor integration 
task. We also investigated the effects of dopaminergic therapy on 
movement-induced STDT modulation. Finally, we investigated 
possible correlations between neurophysiological and clinical 
variables.
MaTerials anD MeThODs
We enrolled 24 patients with Parkinson’s disease (15M/9F; aged 
61 ± 8 years) and 20 age-matched healthy subjects (13M/7F; aged 
59 ±  9  years) at the Department of Neurology and Psychiatry 
of the University of Rome, Sapienza. All the participants gave 
their written informed consent. The experimental procedure was 
approved by the institutional review board at Sapienza University 
Rome and conducted in accordance with the Declaration of 
Helsinki. The diagnosis of PD was based on clinical criteria 
(17, 18). Disease severity was scored using the Hoehn and Yahr 
scale and the MDS-Unified Parkinson’s Disease Rating Scale 
part III (MDS-UPDRS part III). Patients were also evaluated by 
means of the Frontal Assessment Battery (FAB) and the Montreal 
Cognitive Assessment (MOCA) (Table  1). Since data yielded 
by STDT testing are only reliable if there is no clear deficit in 
cognitive functions, patients with a FAB score lower than 15 and 
a MOCA score lower than 24 were excluded. Subjects who had 
a clinically diagnosed peripheral sensory neuropathy were also 
excluded.
All the PD patients were studied OFF therapy (at least 12 h 
after the last dose of oral dopaminergic therapy). Fifteen of the 
24 PD patients were also tested in “ON” state after receiving 
levodopa; the two sessions in these patients were performed in a 
randomized order, at least 1 week apart.
sTDT Testing
STDT was investigated on the volar surface of the index finger 
of the right hand and of the left hand in patients and of the 
right hand in healthy subjects, according to the experimental 
procedures previously used (7, 14, 19, 20). Participants were 
comfortably seated in an armchair beside a table. We delivered 
paired stimuli starting with an interstimulus interval (ISI) of 
0 ms (simultaneous pair), and progressively increased the ISI in 
10-ms steps with a staircase method. Paired tactile stimuli con-
sisted of square-wave electrical pulses delivered using a constant 
current stimulator (Digitimer DS7AH) through surface skin 
electrodes with the anode located 0.5 cm distally to the cathode. 
Stimulation intensity was defined for each subject by delivering a 
series of stimuli at increasing intensities from 2 in 0.5 mA steps; 
the intensity used for STDT testing was the minimal intensity 
the subject perceived in 10 out of 10 consecutive stimuli. The 
first of three consecutive ISIs at which participants recognized 
the stimuli as temporally separate was considered the STDT. To 
keep the subjects’ attention level constant during the test and 
minimize possible perseverative responses, we included “catch” 
trials consisting of a single stimulus delivered randomly.
electromyographic recordings
EMG activity was recorded through surface electrodes placed 
over the FDI muscle, in a belly tendon configuration. EMG sig-
nals were recorded and filtered with a Digitimer D360 (Digitimer 
Ltd., UK) (bandwidth 20  Hz–1  kHz), then analyzed off-line 
with a personal computer through a 1401 plus A/D laboratory 
interface (Cambridge Electronic Design, UK). Data were stored 
on a laboratory computer for on-line visual display and further 
off-line analysis (Signal software; Cambridge Electronic Design).
Kinematic recording
The SMART analyzer motion system (BTS Engineering, Milan, 
Italy), equipped with three infrared cameras (sampling rate, 
120 Hz), was used to record index finger abductions. The arm 
was abducted at the shoulder by about 45–50°, and the elbow 
joint was flexed at about 90°. An optical marker was placed over 
the distal phalanx of the index finger. After a verbal “go” signal, 
subjects abducted the index finger, then returned the finger to the 
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starting position upon being given a verbal “stop” signal shortly 
after (21–23). Marker displacement was reconstructed via a 
dedicated software that runs the automatic algorithm to compute 
the range of motion (ROM), which represents the displacement of 
the index finger around its metacarpophalangeal joint expressed 
as the degree of the angle and mean velocity (degrees per second) 
(BTS Engineering, Milan, Italy).
experimental Design
Experimental procedures envisaged first the assessment of 
basal STDT values (without movement). Participants were then 
instructed to perform index finger movements. Subjects were 
asked to abduct the index finger as widely and as quickly as pos-
sible and were continuously encouraged to do so throughout the 
motor task. Participants performed 10 index finger abductions 
before starting the experiment to familiarize with the motor task 
required (data not entered in the statistical analysis). The experi-
mental tasks consisted of index finger abductions, with the STDT 
being tested on the volar surface of the same index finger. Paired 
stimuli for STDT were triggered by movement execution at vari-
ous time lapses after movement onset. The threshold to identify 
movement onset of index finger abductions was set at 100 μV of 
EMG activity. To define the time course of movement-induced 
STDT changes, paired stimuli were delivered as soon as the EMG 
signals reached 100 μV in amplitude (defined as “0 ms” for sim-
plicity), 100 and 200 ms after movement onset. The STDT values 
were thus calculated for each time lapse (0, 100, and 200 ms). At 
each index finger abduction, the ISI for STDT testing was pro-
gressively increased in 10-ms steps, until the subject recognized 
the two stimuli as sequential (10). Blocks for each time lapse were 
delivered in random order.
statistical analysis
We first checked STDT and kinematic data for normal distribu-
tion using Shapiro–Wilk test. Having excluded any assumption 
violations, we then performed separate between-group ANOVA 
to compare baseline absolute values of STDT and kinematic 
values (ROM and mean velocity) in healthy subjects and patients 
with Parkinson’s disease. To evaluate any difference in the amount 
of STDT modulation and changes in kinematic variables during 
movement execution between patients and healthy subjects, we 
used separate between-group repeated measure ANOVA with fac-
tor GROUP and factor TIME LAPSE (STDT: four levels: baseline, 
0, 100, and 200 ms; kinematic variables: movement only, 0, 100, 
and 200 ms) entering percentage values. To evaluate changes in 
the STDT modulation and kinematic variables induced by dopa-
minergic therapy, we used separate repeated measure ANOVA 
with factor THERAPY (two levels: ON and OFF), SIDE (more 
and less affected hand), and TIME LAPSE (STDT: four levels: 
baseline, 0, 100, and 200 ms; kinematic variables: movement only, 
0, 100, and 200 ms). As a post hoc analysis, we used the paired 
sample T test to compare values at the different time points from 
baseline. Finally, we used Spearman’s correlation coefficient to 
evaluate possible correlations between clinical/demographic 
(age, sex, disease duration, age at onset, UPDRS part III scores, 
and upper limb bradykinesia scores) and neurophysiological 
results. P < 0.05 indicated statistical significance.
resUlTs
PD patients and healthy subjects did not differ in terms of age 
(unpaired sample T test: P = 0.43) and sex (Mann–Whitney U 
test: P = 0.77).
changes in sTDT Values during Movement 
execution in PD Patients and healthy 
subjects
Between-group ANOVA for the STDT values at baseline in 
PD patients and healthy subjects showed that STDT values for 
both hands of PD patients OFF therapy [more affected hand: 
F(1,42) = 26.4, P < 0.0001; less affected hand: F(1,42) = 32.0, P < 0.001] 
as well as ON therapy [more affected hand: F(1,33) = 10.5, P = 0.003, 
less affected hand: F(1,33) = 11.5, P = 0.002] were higher than in 
healthy subjects. No significant difference was observed in the 
baseline STDT values of PD patients between the more affected 
and less affected hand (OFF: P = 0.5; ON: P = 0.73) (Figure 1A).
Index finger abductions significantly increased STDT val-
ues in PD patients in the OFF and ON therapy conditions in 
both hands and in healthy subjects. Between-group ANOVA 
performed to compare changes in STDT values during index 
finger abductions in patients OFF therapy and healthy subjects 
revealed a significant factor GROUP [more affected hand OFF 
therapy: F(1,42) = 7.8, P = 0.008; less affected hand OFF therapy: 
F(1,42) = 4.5, P = 0.03], factor TIME LAPSE [more affected OFF 
therapy: F(3,126) = 40.6, P < 0.000001; less affected OFF therapy: 
F(3,126) =  37.4, P <  0.0001], and a significant GROUP ×  TIME 
LAPSE interaction [more affected OFF therapy: F(3,126)  =  4.0, 
P  =  0.009; less affected OFF therapy: F(3,126)=2.7, P  =  0.048]. 
Between-group ANOVA to compare changes in STDT values 
during index finger abductions in patients ON therapy and 
healthy subjects showed a significant factor TIME LAPSE [more 
affected hand ON therapy: F(3,99) = 33.9, P < 0.0001; less affected 
hand ON therapy: F(3,99) = 32.3, P < 0.0001] but not significant 
GROUP × TIME LAPSE interaction. Post hoc analysis showed 
that the increase in STDT values in healthy subjects was sig-
nificant at 0 ms (P < 0.0001), 100 ms (P = 0.001), and 200 ms 
(P =  0.002). In PD patients in the OFF therapy condition, the 
STDT increased at 0  ms (more affected hand: P <  0.0001, less 
affected hand: P <  0.0001) and 100  ms (more affected hand: 
P = 0.004, less affected hand: P = 0.002) but returned to baseline 
values at 200  ms (more affected hand: P =  0.07, less affected 
hand: P = 0.07). In PD patients ON therapy, the STDT increased 
significantly at 0 ms (more affected hand: P < 0.0001, less affected 
hand: P < 0.0001), 100 ms (more affected: P = 0.002, less affected: 
P = 0.001), and 200 ms (more affected: P = 0.006, less affected: 
P = 0.004) (Figure 1B). Repeated measures ANOVA performed 
to evaluate the effects of dopaminergic therapy on changes in 
the STDT values during index finger abductions in PD patients 
showed a significant factor THERAPY [F(1,14) = 9.8, P = 0.007], 
factor TIME LAPSE [F(3,42) = 26.5, P < 0.001] and a significant 
THERAPY × TIME LAPSE interaction [F(3,42) = 2.7, P = 0.04]. 
STDT values in PD patients were significantly higher OFF 
therapy than ON therapy (Figure 1A). The time course related 
to movement onset associated with the increase in STDT values 
during index finger abductions in PD patients was shorter than 
FigUre 1 | Changes in somatosensory temporal discrimination threshold (STDT) during index finger abductions in patients with Parkinson’s disease, in the ON and 
OFF therapy conditions, and in healthy subjects. (a) STDT at baseline (absolute values); (b) percentage changes of STDT during index finger abductions.
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that observed in healthy subjects when patients were tested OFF 
therapy (increase in STDT was significant at 0 and 100 ms interval 
but not at 200  ms), whereas it was similar to that observed in 
healthy subjects (increase in STDT was significant at 0, 100, and 
200 ms interval) when tested ON therapy (Figure 1B).
changes in Kinematic Features of 
Movements induced by sTDT Testing in 
PD Patients and healthy subjects
Between-group ANOVA performed to compare baseline ROM 
and mean velocity of index finger abductions in PD patients OFF 
and ON therapy and healthy subjects revealed a significant factor 
GROUP [ROM: more affected hand OFF therapy: F(1,42) = 7.7, 
P = 0.008; less affected hand OFF therapy: F(1,42) = 14.0, P = 0.0001; 
more affected hand ON therapy: F(1,33) =  14.3; P <  0.001; less 
affected hand ON therapy: F(1,33) = 6.8, P = 0.01; mean veloc-
ity: more affected hand OFF therapy: F(1,42) = 27.2, P < 0.001; 
less affected hand OFF therapy: F(1,42) = 24.9, P < 0.0001; more 
affected hand ON therapy: F(1,33) = 15.2, P = 0.001; less affected 
hand ON therapy: F(1,33) = 14.4, P = 0.001] (Figure 2A). ROM 
and mean velocity in PD patients were generally lower than that 
in healthy subjects in the OFF and ON therapy and in more 
affected and less affected hands.
Between-group repeated measure ANOVA to compare per-
centage changes in ROM during index finger abductions in PD 
patients and in healthy subjects across the various time lapses 
tested showed a significant factor GROUP [only for more affected 
hand OFF: F(1,42) = 4.7,  P = 0.03], but no significant factor TIME 
LAPSE (all Ps >  0.05) or TIME LAPSE ×  GROUP interaction 
(all Ps > 0.05).
Between-group repeated measure ANOVA performed to 
compare changes in mean velocity of index finger abductions 
in PD patients OFF and ON therapy and healthy subjects 
revealed a significant factor GROUP [more affected hand 
OFF therapy: F(1,42) =  24.8, P <  0.001; less affected hand OFF 
therapy: F(1,42)  =  91.0, P  <  0.0001; more affected hand ON 
therapy: F(1,33) = 99.1, P < 0.0001; less affected hand ON therapy: 
F(1,33) =  16.3, P <  0.001], factor TIME LAPSE [more affected 
hand OFF therapy: F(3,126) = 7.4, P = 0.0001; less affected hand 
OFF therapy: F(3,126) = 7.9, P < 0.0001; more affected hand ON 
therapy: F(3,99) = 10.7, P = 0.0001; less affected hand ON therapy: 
F(3,99) = 6.1, P = 0.001], and a significant GROUP × TIME LAPSE 
interaction [more affected hand OFF therapy: F(3,126)  =  8.5, 
P < 0.001; less affected hand OFF therapy: F(3,126) = 8.4, P = 0.001; 
more affected hand ON therapy: F(3,99) =  10.8, P <  0.001; less 
affected hand ON therapy: F(3,99) = 6.02, P = 0.001]. Index finger 
abductions were slower in both hands in PD patients OFF therapy 
FigUre 2 | Changes in mean velocity of index finger abductions without somatosensory temporal discrimination threshold (STDT) and during STDT testing at 
different intervals from movement onset in patients with Parkinson’s disease, ON and OFF therapy, and in healthy subjects. (a) Mean velocity (absolute values)  
of index finger abductions without STDT testing. (b) Y axis: percentage changes in mean velocity.
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than either in those ON therapy or in healthy subjects at all the 
time lapses tested (movement only, 0, 100, and 200 ms interval). 
Post hoc analysis performed to evaluate percentage changes in the 
mean velocity of index finger abductions during STDT testing 
showed that the mean velocity in PD patients, unlike that in 
healthy subjects (in whom the mean velocity was not affected 
by STDT testing) (P > 0.05), significantly decreased across time 
lapses, with lower values being recorded at 200 ms (more affected 
hand OFF therapy: P < 0.001; less affected hand OFF therapy: 
P < 0.001; more affected hand ON therapy: P < 0.001; less affected 
hand ON therapy: P = 0.001) than at 0 ms interval (Figure 2B).
ANOVA performed to analyze changes in ROM induced 
by dopaminergic therapy in PD patients revealed a significant 
HAND × THERAPY × TIME LAPSE interaction [F(3,42) =  7.4, 
P  =  0.001]. When PD patients were tested in OFF therapy 
condition ROM slightly decreased across ISIs, being smaller at 
200 ms interval in comparison to 0 ms interval, whereas, when 
PD patients were tested in the ON therapy condition, similar to 
healthy subjects, ROM remained unchanged across time lapses.
ANOVA performed to assess the changes in mean velocity 
of index finger abductions of the more affected and less affected 
hands in PD patients ON and OFF therapy disclosed a sig-
nificant factor TIME LAPSE [F(3,42) =  38.8, P <  0.0001], and a 
significant TIME LAPSE  ×  HAND  ×  THERAPY interaction 
[F(3,42) = 5.56, P = 0.002]. In PD patients, dopaminergic therapy 
increased the mean velocity in both the less affected and the 
more affected hand. The increase in mean velocity induced by 
dopaminergic medication was more evident at the 0 ms than at 
200 ms interval, as well as in the less affected hand than in the 
more affected hand (changes in mean velocity in comparison to 
baseline values: less affected hand ON 0 ms interval: P = 0.96; 
200 ms interval: P < 0.01; less affected hand OFF 0 ms interval: 
P <  0.0001; 200  ms interval: P <  0.00001; more affected hand 
ON: 0 ms interval: P = 0.02; 200 ms interval: P < 0.001; more 
affected hand OFF: 0  ms interval: P =  0.007; 200  ms interval: 
P  <  0.00001) (Figure  2B). Dopaminergic therapy therefore 
increased the velocity of index finger abductions during STDT 
testing when paired electrical stimuli were given concomitantly 
FigUre 3 | Correlation between changes in mean velocity [mean velocity of 
index finger abductions in the 200 ms interstimulus interval (ISI) trial 
expressed as percentage of mean velocity at the 0 ms ISI trial] in the more 
affected hand and UPDRS part III score in the OFF therapy condition.
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with movement onset, but improved the mean velocity to a lesser 
extent when STDT was tested during the ongoing phase of the 
movement (200 ms interval).
Changes in mean velocity in the more affected hand OFF 
therapy at 200 ms interval were inversely related to the UPDRS 
part III score OFF therapy (r = −0.52, P = 0.008) (Figure 3). We 
did not observe any other significant relationship between the 
neurophysiological findings and demographic and clinical data 
(age, sex, age at onset, and disease duration). We only found a 
trend toward significance for relationship between changes 
in mean velocity in the more affected hand OFF therapy at 
200 ms interval and the more affected hand bradykinesia scores 
(r = −0.49, P = 0.08).
DiscUssiOn
The results of this study first confirm that STDT values are higher 
in PD patients than in healthy subjects (6, 11–16, 19). The novel 
finding of our study is that when the STDT was tested during index 
finger movements, in healthy subjects it increased significantly at 
0, 100, and 200 ms intervals after movement onset, whereas in PD 
patients in the OFF therapy condition, it increased significantly at 
0 and 100 ms but returned to baseline values at 200 ms. When PD 
patients were tested under dopaminergic medication, the STDT 
values during index finger abductions increased significantly, 
with a time course similar to that of healthy subjects. The other 
novel finding of our study was that while STDT testing during 
index finger abductions in healthy subjects did not result in 
any changes in the movement kinematics, in PD patients the 
mean velocity of the finger abductions decreased according to 
the time lapse between movement onset and the delivery of the 
paired electrical stimuli for STDT testing. Finally, dopaminergic 
medication increased the mean velocity of index finger abduc-
tions during STDT testing when paired electrical stimuli were 
delivered in the initial phase of movement, but failed to improve 
movement performance when the paired electrical stimuli were 
delivered during the ongoing movement.
Since we randomized the order of the trials testing the dif-
ferent time lapses between movement onset and paired stimuli 
for STDT, we are confident that changes in the STDT values and 
in movement kinematics did not depend on different attention 
levels or fatigue. Similarly, we alternated the order of the OFF and 
ON medication conditions. Thus, since the time lapses and medi-
cation conditions were randomized, the changes we observed in 
movement kinematics at different time lapses suggest that they 
were due specifically to the time lapse between movement onset 
and paired electrical stimuli. We also rule out that the time course 
of the STDT changes during index finger abductions in the OFF 
therapy condition was due to the higher baseline STDT values in 
PD patients because the STDT increased significantly at 0 and 
100 ms. Moreover, with the stepwise method, we used for STDT, a 
floor effect might occur in experimental protocols in which STDT 
values are expected to decrease below the threshold, whereas 
values may increase to a considerable extent above the threshold.
The distinctive finding of our study is that temporal coupling 
of tactile sensory information processing and motor outflow is 
altered in PD patients, which extends our knowledge by bridging 
the gap between altered temporal processing of sensory informa-
tion and motor symptoms. We show that sensory information 
processing related to STDT is abnormally gated during move-
ment execution in PD patients OFF therapy if compared with 
healthy subjects and those ON therapy. Using our time-controlled 
experimental paradigm, we now provide evidence that tactile 
information gating is less efficient in PD patients than in healthy 
subjects, as indicated by the observation that STDT values of PD 
patients OFF therapy returned to those at baseline when STDT 
was tested 200 ms after movement onset, whereas the STDT was 
still gated in healthy subjects at this time interval. We therefore 
hypothesize that dopaminergic depletion in PD not only affects 
sensory processing in the temporal domain but also alters the 
temporal coupling between tactile information and motor out-
flow. Consistent with previous observations (6, 16, 19, 24) dopa-
mine improved although not normalized STDT abnormalities. 
l-DOPA likely improves the time-related interaction between 
corticosubcortical structures (9, 16, 19) but fails to intervene in 
the dysfunctional non-dopaminergic mechanisms (14, 24–27). 
The novel finding of our study is that when PD patients were 
tested under dopaminergic therapy the STDT modulation during 
movement execution had a time course similar to that observed in 
healthy subjects. Thus, the normalized STDT modulation in PD 
patients in the ON medication condition suggests that abnormal 
sensorimotor integration we tested reflects dopaminergic loss 
and the basal ganglia contribution in this task.
In keeping with previous studies (28–30), index finger abduc-
tions in our PD patients were slower and of lower amplitude 
than those obtained from healthy subjects. We also confirm 
that dopaminergic therapy improves the mean velocity of index 
finger abductions (24, 31). The unexpected novel finding of our 
study is that kinematic features of index finger abductions in PD 
patients, unlike healthy subjects, changed according to the time 
lapse between paired electrical stimuli and movement onset, 
7Conte et al. Temporal Processing and Movement in PD
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with slower values being observed when 200 ms elapsed between 
movement onset and paired stimuli for STDT than when paired 
stimuli were delivered concomitantly with movement onset. 
Since the performance of PD patients worsens during dual task 
procedures (32–34), one explanation for the decrease in the mean 
velocity of index finger abductions during STDT testing in PD 
patients might be the dual task design of our experimental proto-
col. However, we can exclude this hypothesis since changes in the 
mean velocity of index finger abductions were significant only at 
200 ms all the intervals tested implied a dual task effect. The time 
interval between the paired stimuli and movement onset thus 
seems to play a crucial role in changes in movement kinematics 
and in STDT gating. We may speculate that when STDT process-
ing is not properly gated (as suggested by the observation that 
STDT values returned to baseline in the OFF therapy condition 
at 200 ms interval), movement performance deteriorates in terms 
of velocity. Since in PD sensory gating alterations in the temporal 
domain parallel disease severity (14), we hypothesize that the 
more altered temporal sensory processing is, the worse the effect 
of abnormal sensory gating on sensorimotor integration. This 
hypothesis is supported to some extent by the inverse relationship 
we found between the STDT-induced decrease in mean velocity at 
200 ms interval and the UPDRS score in the OFF therapy assess-
ment. Whereas previous studies have provided indirect evidence 
showing that STDT abnormalities may contribute to impaired 
finger dexterity in PD (15, 35) we now show that altered temporal 
processing of tactile information affects movement execution by 
inducing abnormal temporal coupling of the two systems. Why 
sensorimotor integration unexpectedly fails when the movement 
is ongoing and not at movement onset deserves a comment. Since 
both patients and healthy subjects were blind to the time intervals 
between movement onset and paired stimuli for STDT and since 
the order of the time intervals was randomized, we can rule 
out the possibility that subjects expected the paired stimuli and, as 
they perceived no stimuli immediately after movement onset, the 
velocity of index finger movements consequently slowed down. 
If this were the case, the mean velocity would have decreased 
at the 200  ms interval even in healthy subjects. In addition, 
the finding that mean velocity did not vary in healthy subjects 
and decreased at 200  ms in patients regardless of the order of 
presentation of the time lapses goes against the presence of an 
aspecific expectation-related effect. An animal model of PD has 
shown that dopamine depletion reduces the level of selectivity 
of information that passes through the basal ganglia–cortical 
loops (36, 37), with a reduced signal-to-noise ratio resulting in 
a selection deficit between high- and low-priority information 
in movement execution. The consequent information overflow 
back to the cortex may alter the motor programs needed to adapt 
movement to context. The hypothesis which in our opinion best 
explains the decreased mean velocity at the 200 ms interval in 
PD patients is that, following the loss of selectivity in the basal 
ganglia–thalamus interplay (16, 37, 38), the motor program 
underlying movement execution becomes more susceptible to 
interference when it is ongoing and not sufficiently energized. 
Dopaminergic depletion reduces the ability of basal ganglia to 
remove inhibitory influences from the desired motor output, 
which normally allows the movement to proceed when already 
initiated (38). In this view, our experimental protocol implies that 
the electrical stimuli for STDT testing at 0 and 100 ms intervals 
are processed in the initial phase of movement, whereas at 200 ms 
interval they are processed during the ongoing movement. 
Alternative to a specific alteration of tactile–motor integration, 
we may hypothesize that 200 ms time lapse between movement 
onset and electrical stimuli for STDT may be a time window 
that makes the ongoing movement susceptible to a distractive 
effect induced by electrical stimulation. Transient attention can 
dynamically modulate perception when an unexpected stimulus 
is presented (39) and event-related potentials studies have shown 
that transient attention dynamically modulate SEP components 
beyond 100  ms (39). Our experimental protocol, however, 
implied that subjects were aware of the electrical stimuli in the 
task, insofar electrical stimuli were unlikely unexpected. Future 
studies in PD patients investigating whether ongoing movement 
is susceptible to external interference also with other sensory 
modalities may clarify whether changes in movement velocity 
during sensorimotor integration relies on attention-mediated 
processes.
In conclusion, altered tactile–motor integration, in addition 
to the previously reported proprioceptive–motor integration 
(15, 16, 35, 40–44), may contribute to the development of move-
ment deficits in Parkinson’s disease. Our findings also show that 
dopaminergic therapy normalizes STDT gating and to some 
extent compensates for the decreased velocity of index finger 
abductions at 200 ms interval. Finally, we extend the significance 
of our findings to the clinical field by suggesting that studies aimed 
at developing devices designed to improve motor disturbances in 
PD patients, through mechanisms of sensorimotor integration, 
should take into account the precise timing of the external sen-
sory cue in relation to the movement phase. Future confirmatory 
studies manipulating sensory information processing and motor 
behavior in PD are needed to definitively clarify the link between 
the abnormal temporal processing of sensory information and 
the pathophysiology of specific motor disturbances in PD.
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